Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Jul;33(1):315–318. doi: 10.1128/iai.33.1.315-318.1981

Polymyxin B Inactivation of Lipopolysaccharide in Vaccines of Gram-Negative Bacteria

Michael Cooperstock 1, Linda Riegle 2
PMCID: PMC350693  PMID: 6266967

Abstract

Endotoxin activity in suspensions of Bordetella pertussis, Escherichia coli, Haemophilus influenzae, and Pseudomonas aeruginosa was often markedly decreased by polymyxin B. Polymyxin B treatment may be a means to reduce inflammatory reactivity of lipopolysaccharide in vaccines of gram-negative bacteria.

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMSON R. H., MARSHALL F. N., LONG J. P. Neuromuscular-blocking properties of various polypeptide antibiotics. Proc Soc Exp Biol Med. 1960 Dec;105:494–497. doi: 10.3181/00379727-105-26154. [DOI] [PubMed] [Google Scholar]
  2. BUSHBY S. R., GREEN A. F. The release or histamine by polymyxin B and polymyxin E. Br J Pharmacol Chemother. 1955 Jun;10(2):215–219. doi: 10.1111/j.1476-5381.1955.tb00085.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bader J., Teuber M. Action of polymyxin B on bacterial membranes. 1. Binding to the O-antigenic lipopolysaccharide of Salmonella typhimurium. Z Naturforsch C. 1973 Jul-Aug;28(7):422–430. [PubMed] [Google Scholar]
  4. Bannatyne R. M., Harnett N. M., Lee K. Y., Biggar W. D. Inhibition of the biologic effects of endotoxin on neutrophils by polymyxin B sulfate. J Infect Dis. 1977 Oct;136(4):469–474. doi: 10.1093/infdis/136.4.469. [DOI] [PubMed] [Google Scholar]
  5. Chen C. H., Johnson A. G., Kasai N., Key B. A., Levin J., Nowotny A. Heterogeneity and biological activity of endotoxic glycolipid from Salmonella minnesota R595. J Infect Dis. 1973 Jul;128(Suppl):43–51. doi: 10.1093/infdis/128.supplement_1.s43. [DOI] [PubMed] [Google Scholar]
  6. Cooperstock M. S. Inactivation of endotoxin by polymyxin B. Antimicrob Agents Chemother. 1974 Oct;6(4):422–425. doi: 10.1128/aac.6.4.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Corrigan J. J., Jr, Bell B. M. Endotoxin-induced intravascular coagulation: prevention with polymyxin B sulfate. J Lab Clin Med. 1971 May;77(5):802–810. [PubMed] [Google Scholar]
  8. Corrigan J. J., Jr, Sieber O. E., Jr, Ratajczak H., Bennett B. B. Modification of human neutrophil response to endotoxin with polymyxin B sulfate. J Infect Dis. 1974 Oct;130(4):384–387. doi: 10.1093/infdis/130.4.384. [DOI] [PubMed] [Google Scholar]
  9. Craig W. A., Turner J. H., Kunin C. M. Prevention of the generalized Shwartzman reaction and endotoxin lethality by polymyxin B localized in tissues. Infect Immun. 1974 Aug;10(2):287–292. doi: 10.1128/iai.10.2.287-292.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dufer J., Benoist H., Choppin J., Desplaces A. Synthèse d'ADN et synthèse d'anticorps dans les cellules spléniques de la souris, après immunisation, in vivo, par le lipopolysaccharide d'Escherichia coli, modifié par la polymyxine B. C R Seances Acad Sci D. 1980 Mar 17;290(11):699–701. [PubMed] [Google Scholar]
  11. Elin R. J., Sandberg A. L., Rosentreich D. L. Comparison of the pyrogenicity, Limulus activity mitogenicity and complement reactivity of several bacterial endotoxins and related compounds. J Immunol. 1976 Oct;117(4):1238–1242. [PubMed] [Google Scholar]
  12. FEW A. V. The interaction of polymyxin E with bacterial and other lipids. Biochim Biophys Acta. 1955 Jan;16(1):137–145. doi: 10.1016/0006-3002(55)90191-8. [DOI] [PubMed] [Google Scholar]
  13. Flesher A. R., Insel R. A. Characterization of lipopolysaccharide of Haemophilus influenzae. J Infect Dis. 1978 Dec;138(6):719–730. doi: 10.1093/infdis/138.6.719. [DOI] [PubMed] [Google Scholar]
  14. From A. H., Fong J. S., Good R. A. Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs. Infect Immun. 1979 Mar;23(3):660–664. doi: 10.1128/iai.23.3.660-664.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Inada K. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. II. Complement activating property of the lipopolysaccharide portion and the inhibition by polymyxin B. Jpn J Exp Med. 1980 Apr;50(2):107–115. [PubMed] [Google Scholar]
  16. Jacobs M. D., Morrison D. C. Dissociation between mitogenicity and immunogenicity of TNP-lipopolysaccharide, a T-independent antigen. J Exp Med. 1975 Jun 1;141(6):1453–1458. doi: 10.1084/jem.141.6.1453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kreeftenberg J. G., Loggen H. G., van Ramshorst J. D., Beuvery E. C. The limulus amebocyte lysate test micromethod and application in the control of sera and vaccines. Dev Biol Stand. 1977;34:15–20. [PubMed] [Google Scholar]
  18. Kuronen T., Peltola H., Nors T., Haque N., Mäkelä P. H. Adverse reactions and endotoxin content of polysaccharide vaccines. Dev Biol Stand. 1977;34:117–125. [PubMed] [Google Scholar]
  19. Kusano T., Izaki K., Takahashi H. Degradation of phospholipid in Pseudomonas aeruginosa induced by polymyxin B. J Antibiot (Tokyo) 1975 Sep;28(9):689–695. doi: 10.7164/antibiotics.28.689. [DOI] [PubMed] [Google Scholar]
  20. Levin J. The Limulus test: a status report. Prog Clin Biol Res. 1979;29:235–244. [PubMed] [Google Scholar]
  21. Morrison D. C., Jacobs D. M. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. 1976 Oct;13(10):813–818. doi: 10.1016/0019-2791(76)90181-6. [DOI] [PubMed] [Google Scholar]
  22. Morrison D. C., Jacobs D. M. Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B. Infect Immun. 1976 Jan;13(1):298–301. doi: 10.1128/iai.13.1.298-301.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. NETER E., GORZYNSKI E. A., WESTPHAL O., LUDERITZ O. The effects of antibiotics on enterobacterial lipopolysaccharides (endotoxins), hemagglutination and hemolysis. J Immunol. 1958 Jan;80(1):66–72. [PubMed] [Google Scholar]
  24. Nandan R., Brown D. R. An improved in vitro pyrogen test: to detect picograms of endotoxin contamination in intravenous fluids using limulus amoebocyte lysate. J Lab Clin Med. 1977 Apr;89(4):910–918. [PubMed] [Google Scholar]
  25. Palmer J. D., Rifkind D. Neutralization of the hemodynamic effects of endotoxin by polymyxin B. Surg Gynecol Obstet. 1974 May;138(5):755–759. [PubMed] [Google Scholar]
  26. Rifkind D., Hill R. B., Jr Neutralization of the Shwartzman reactions by polymyxins B. J Immunol. 1967 Sep;99(3):564–569. [PubMed] [Google Scholar]
  27. Rifkind D., Palmer J. D. Neutralization of endotoxin toxicity in chick embryos by antibiotics. J Bacteriol. 1966 Oct;92(4):815–819. doi: 10.1128/jb.92.4.815-819.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rifkind D. Prevention by polymyxin B of endotoxin lethality in mice. J Bacteriol. 1967 Apr;93(4):1463–1464. doi: 10.1128/jb.93.4.1463-1464.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Smith E., Hammarström L., Coutinho A. Association between mitogenicity and immunogenicity of 4-hydroxy-3,5-dinitrophenacetyl-lipopolysaccharide, a T-independent antigen. J Exp Med. 1976 Jun 1;143(6):1521–1527. doi: 10.1084/jem.143.6.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Storm D. R., Rosenthal K. S., Swanson P. E. Polymyxin and related peptide antibiotics. Annu Rev Biochem. 1977;46:723–763. doi: 10.1146/annurev.bi.46.070177.003451. [DOI] [PubMed] [Google Scholar]
  31. Tomasulo P. A. Correlation of Limulus amebocyte lysate assay with accepted endotoxin assays. Prog Clin Biol Res. 1979;29:293–302. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES